Evidence map›Paper›PMID 38637025›Full record

ArticleAJNR. American journal of neuroradiology2024

Brain Arteriovenous Malformation In Vitro Model for Transvenous Embolization Using 3D Printing and Real Patient Data.

Rodrigo Rivera, Alvaro Cespedes, Juan Pablo Cruz, Aymeric Rouchaud, Charbel Mounayer

Open access · hybridAbstract read
In one paragraph

Article in AJNR. American journal of neuroradiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Rodrigo RiveraFrom the Neuroradiology Department (R.R., J.P.C.), Instituto de Neurocirugia Dr. Asenjo, Santiago, Chile rodrigorivera@me.com.ORCID 0000-0001-8991-0972
Alvaro CespedesDepartment of Design and Manufacturing (A.C.), Universidad Tecnica Federico Santa Maria, Chile.
Juan Pablo CruzFrom the Neuroradiology Department (R.R., J.P.C.), Instituto de Neurocirugia Dr. Asenjo, Santiago, Chile.ORCID 0000-0002-7524-7273
Aymeric RouchaudCNRS XLIM UMLR 7252 (R.R., A.R., C.M.), Université de Limoges, Limoges, France.ORCID 0000-0003-0902-3375
Charbel MounayerCNRS XLIM UMLR 7252 (R.R., A.R., C.M.), Université de Limoges, Limoges, France.ORCID 0000-0002-5894-9599
Centre National de la Recherche Scientifique · FRFederico Santa María Technical University · CLInstituto de Neurociencia Biomédica · CL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposeTransvenous embolization has emerged as a novel technique for treating selected brain AVMs with high reported occlusion rates. However, it requires anatomic and technical skills to be successful and to ensure patient safety. Therefore, training and testing are essential for preparing clinicians to perform these procedures. Our aim was to develop and test a novel, patient-specific brain AVM in vitro model for transvenous embolization by using 3D printing technology. MATERIALS AND

methodsWe developed a brain AVM in vitro model based on real patient data by using stereolithography resin 3D printing. We created a closed pulsed circuit with flow passing from the arterial side to the venous side, and we tested the effect of mean arterial pressure on retrograde nidal filling with contrast injections. Transvenous embolization simulations were conducted for each of the 12 identical models divided into 2 groups (2×6). This involved the use of an ethylene-vinyl alcohol liquid embolic agent injected through microcatheters either without or with a coil in the vein (groups 1 and 2, respectively).

resultsRetrograde contrast advance to nidus was directly related to lower mean arterial pressure. Transvenous embolization tests with a liquid embolic agent adequately reproduced the usual embolization plug and push technique. We found no differences between the 2 group conditions, and additional venous coil neither increased nidus penetration nor reduced injection time in the model (57.6 versus 61.2% nidus occlusion rate, respectively).

conclusionsWe were able to develop and test a functional in vitro brain AVM model for transvenous embolization by using 3D printing to emulate its conditions and characteristics. Better contrast penetration was achieved with less mean arterial pressure, and no embolization advantage was found by adding coil to the vein in this model.

Indexed as

Embolization, TherapeuticIntracranial Arteriovenous MalformationsPrinting, Three-DimensionalHumansModels, Anatomic

Identifiers

PMID38637025
PMCPMC11288534
OpenAlexW4394909691

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.